ArrayExpress Uploader0humanMDD patientbefore treatmentMDD patientbefore treatmentMDD patientbefore treatmentMDD patientbefore treatmentMDD patientbefore treatmenthealthy controlnot specifiedhealthy controlnot specifiedhealthy controlnot specifiedhealthy controlnot specifiedhealthy controlnot specifiedhealthy controlnot specifiedhealthy controlnot specifiedhealthy controlnot specifiedSSD patientbefore treatmentSSD patientbefore treatmentSSD patientafter treatment with VenlafaxineMDD patientbefore treatmentMDD patientafter treatment with VenlafaxineMDD patientbefore treatmentMDD patientafter treatment with VenlafaxineSSD patientbefore treatmentMDD patientbefore treatmentMDD patientafter treatment with VenlafaxineMDD patientafter treatment with VenlafaxineSSD patientbefore treatmentSSD patientafter treatment with VenlafaxineSSD patientbefore treatmentSSD patientafter treatment with VenlafaxineSSD patientbefore treatmentSSD patientafter treatment with VenlafaxineSSD patientbefore treatmentMDD patientafter treatment with VenlafaxineSSD patientbefore treatmentSSD patientafter treatment with VenlafaxineMDD patientafter treatment with VenlafaxineMDD patientafter treatment with VenlafaxineMDD patientafter treatment with Venlafaxine4236arrayexpress_sid4Several studies have suggested that SSD is a transitory phenomena in the depression spectrum and is thus considered a subtype of...E-GEOD-32280/profile/8773/arrayexpressuploader237genomemajor depressive disorderDec.12, 2014Falseexpression-data-from-peripheral-blood-lymphocytesE-GEOD-32280_A-AFFY-44Expression data from peripheral blood lymphocytes of major depression, subsyndromal symptomatic depression, and healthy controlsSep.16, 2014Several studies have suggested that SSD is a transitory phenomena in the depression spectrum and is thus considered a subtype of depression. However, the pathophysioloy of depression remain largely obscure and studies on SSD are limited. The present study compared the expression profile and made the classification with the leukocytes by using whole-genome cRNA microarrays among drug-free first-episode subjects with SSD, MDD, and healthy controls. We used microarrays to detail the global programme of gene expression to develop blood-based gene expression profiles models for classification of subsyndromal symptomatic depression and major depressive disorder The present study compared the expression profile and made the classification with the leukocytes by using whole-genome cRNA microarrays among drug-free first-episode subjects with SSD, MDD, and matched controls (8 subjects in each group). Support vector machines (SVMs) were utilized for training and testing on candidate signature expression profiles from signature selection step.http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-32280http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-32280/samples/